Clinical profile of gilteritinib in Japanese patients with relapsed/refractory acute myeloid leukemia: An open ‐label phase 1 study
Cancer Science,Volume 109, Issue 10, Page 3235-3244, October 2018.
Source: Cancer Science - Category: Cancer & Oncology Authors: Kensuke Usuki,
Toru Sakura,
Yukio Kobayashi,
Toshihiro Miyamoto,
Hiroatsu Iida,
Satoshi Morita,
Erkut Bahceci,
Masahito Kaneko,
Mikiko Kusano,
Shunsuke Yamada,
Shigeru Takeshita,
Shuichi Miyawaki,
Tomoki Naoe Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Japan Health | Leukemia | Science | Study